Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07377279
What this trial is testing

Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 384
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Testing effectiveness (Phase 2)Study completedNCT00003796
What this trial is testing

Irofulven in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT05903846
What this trial is testing

The Effect of Oketani Massage on Breastfeeding Success and Breast Engorgement in Mothers Delivering by Cesarean Section

Who this might be right for
BreastfeedingEngorgement of Breast Associated With Childbirth, Postpartum
Agri Ibrahim Cecen University 116
Not applicableNot Yet RecruitingNCT07244588
What this trial is testing

Shaving as an Safe Alternative to Frozen Section Analysis

Who this might be right for
Early Stage Breast Cancer
Mark Ezzat Gerges 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Not applicableStudy completedNCT02910986
What this trial is testing

Behavioral and Psychological Impact of Returning Breast Density Results to Latinas

Who this might be right for
Breast Cancer
Mayo Clinic 1,386
Testing effectiveness (Phase 2)WithdrawnNCT00478270
What this trial is testing

Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Who this might be right for
PainBone NeoplasmNeoplasm Metastasis
Hoffmann-La Roche
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Not applicableStudy completedNCT00156273
What this trial is testing

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center 69
Not applicableUnknownNCT06313073
What this trial is testing

Neoadjuvant Radiotherapy for Breast Cancer

Who this might be right for
Neoadjuvant RadiotherapyBreast Cancer
Changhai Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06444269
What this trial is testing

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT06492005
What this trial is testing

A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd. 160
Not applicableNot Yet RecruitingNCT07017894
What this trial is testing

Applying Breast Mask Containing Cabbage Leaves Extract to Relieve Breast Discomfort in Breastfeeding Women

Who this might be right for
Breast Engorgement
Taipei Veterans General Hospital, Taiwan 154
Not applicableUnknownNCT01609894
What this trial is testing

Individualized Fortification of Breast Milk

Who this might be right for
Postnatal Growth DisorderNeurodevelopment
McMaster Children's Hospital 112
Not applicableUnknownNCT05051956
What this trial is testing

Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

Who this might be right for
Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors
Namik Kemal University 140
Not applicableEnded earlyNCT00146029
What this trial is testing

Companion Pharmacogenetic Study to UMCC 9900/9901

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center
Early research (Phase 1)Study completedNCT05344729
What this trial is testing

Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects

Who this might be right for
Recurrent/Metastatic Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT04720729
What this trial is testing

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer

Who this might be right for
HER2-negative Metastatic Breast Cancer
Institut Curie 160
Next Page